Skip to main content
SpringerLink
Log in

Geriatric Fungal Infections

  • Chapter
Diagnosis of Aging Skin Diseases

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Loo DS. Cutaneous fungal infections in the elderly. Dermatol. Clin. North. Am. 2004; 22: 33–50.

    Google Scholar 

  2. Crespo Erchiga V, Ojeda Martos A, Vera Casano A, et al. Malassezia globosa as the causative agent of pytiriasis versicolor. Br. J. Dermatol. 2000; 143: 799–803.

    Article  PubMed  CAS  Google Scholar 

  3. Gupta AK, Jain HC, Lynde CW, et al. Prevalence and epidemiology of onychomycosis in patients visiting physicians’ offices: a multicenter Canadian Survey of 15,000 patients. J. Am. Acad. Dermatol. 2000; 43: 244–8.

    Article  PubMed  CAS  Google Scholar 

  4. Habif, TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy, 4th ed. Mosby, Inc, 2004.

    Google Scholar 

  5. Elewski BE. Large-scale epidemiological study of the causal agents of onychomycosis: mycological findings from the Multicenter Onychomycosis Study of Terbinafine. Arch. Dermatol. 1997; 133: 1317–18.

    Article  PubMed  CAS  Google Scholar 

  6. Midgley G, Moore MK. Onychomycosis. Rev. Iberoam. Micol. 1998; 15: 113–7.

    PubMed  CAS  Google Scholar 

  7. Daniel III CR, Elewski BE. The diagnosis of nail fungus infection revisited. Arch. Dermatol. 2000; 136: 1162–4.

    Article  Google Scholar 

  8. Elewski BE, Leyden J, Rinaldi MG, et al. Office practice-based confirmation of onychomycosis: a US nationwide prospective survey. Arch. Intern. Med. 2002; 162: 2133–8.

    Article  PubMed  Google Scholar 

  9. Elewski BE. New developments in cutaneous fungal infections. Curr. Probl. Dermatol. 2000; 12: 81–5.

    Article  Google Scholar 

  10. Friedlander SF, Aly R, Krafchik B, et al. Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration- finding study. Pediatrics 2002; 109: 602–7.

    Article  PubMed  Google Scholar 

  11. Lipozencic J, Skerlev M, Orofino-Costa R, et al. A randomized, double-blind, parallel-group, duration- finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species. Br. J. Dermatol. 2002; 146: 816–23.

    Article  PubMed  CAS  Google Scholar 

  12. Lesher JL Jr. Oral therapy of common superficial fungal infections of the skin. J. Am. Acad. Dermatol. 1999; 40: S31–4. Review.

    Article  PubMed  Google Scholar 

  13. Faergemann J, Anderson C, Hersle K, et al. Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis. J. Am. Acad. Dermatol. 1995; 32: 750–3.

    Article  PubMed  CAS  Google Scholar 

  14. Havu V, Heikkila H, Kuokkanen K, et al. A double-blind, randomized study to compare the efficacy and safety of terbinafine (Lamisil) with fluconazole (Diflucan) in the treatment of onychomycosis. Br. J. Dermatol. 2000; 142: 97–102.

    Article  PubMed  CAS  Google Scholar 

  15. De Backer M, De Vroey C, Lesaffre E, et al. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day. J. Am. Acad. Dermatol. 1998; 38: S57–63.

    Article  PubMed  Google Scholar 

  16. Hunger RE, Paredes BE, Quattroppani C, et al. Primary cutaneous cryptococcosis in a patient with systemic immunosuppression after liver transplantation. Dermatology 2000; 200: 352–5.

    Article  PubMed  CAS  Google Scholar 

  17. Lauerma AI, Jeskanen L, Rantanen T, et al. Cryptococcosis during systemic glucocorticoid treatment. Dermatology 1999; 199: 180–2.

    Article  PubMed  CAS  Google Scholar 

  18. Hernandez AD. Cutaneous cryptococcosis. Dermatol. Clin. 1989; 7: 269–74.

    PubMed  CAS  Google Scholar 

  19. Williams DM, Krick JA, Remington JS. Pulmonary infection in the compromised host (Part 1). Am. Rev. Respir. Dis. 1976; 114: 359–94.

    PubMed  CAS  Google Scholar 

  20. Tomasini C, Caliendo V, Puiatti P, et al. Granulomatous-ulcerative vulvar cryptococcosis in a patient with advanced HIV disease. J. Am. Acad. Dermatol. 1997; 37: 116–7.

    Article  PubMed  CAS  Google Scholar 

  21. Murakawa GJ, Kerschmann R. Berger T. Cutaneous cryptococcal infection and AIDS. Report of 12 cases and review of literature. Arch. Dermatol. 1996; 132: 545–8.

    Article  PubMed  CAS  Google Scholar 

  22. Sugar AM. Overview: cryptococcosis in patients with AIDS. Myocpathologia 1991; 114: 153–7.

    Article  CAS  Google Scholar 

  23. Kozel TR, Gotschlich EC. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J. Immunol. 1982; 129: 1675–80.

    PubMed  CAS  Google Scholar 

  24. Hamann ID, Gillespie RJ, Ferguson JK. Primary cryptococcal cellulitis caused by Cryptococcus neoformansvar gatti in an immunocompetent host. Australas J. Dermatol. 1997; 38: 29–32.

    Article  PubMed  CAS  Google Scholar 

  25. Patel P, Ramanathan J, Kayser M, Baran J Jr. Primary cutaneous cryptococcosis of the nose in an immunocompetent woman. J. Am. Acad. Dermatol. 2000; 43: 344–5.

    Article  PubMed  CAS  Google Scholar 

  26. Hecker MS, Weinberg JM. Cutaneous cryptococcosis mimicking keloid. Dermatology 2001; 202: 78–9.

    Article  PubMed  CAS  Google Scholar 

  27. Borton LK, Wintroub BU. Disseminated cryptococcosis presenting as herpetiform lesions in a homosexual man with aquired immunodeficiency syndrome. J. Am. Acad. Dermatol. 1984; 10: 387–90.

    Article  PubMed  CAS  Google Scholar 

  28. Picon L, Vaillant L, Duong T, et al. Cutaneous cryptococcosis resembling molluscum contagiosum: a first manifestation of AIDS. Acta Derm. Venereol. 1989; 69: 365–7.

    PubMed  CAS  Google Scholar 

  29. Gordon PM, Omerod AD, Harvey G, et al. Cutaneous cryptococcal infection without immunodeficiency. Clin. Exp. Dermatol. 1994; 19: 181–4.

    Article  PubMed  CAS  Google Scholar 

  30. Sussman EJ, McMahon F, Wright D, et al. Cutaneous cryptococcosis without evidence of systemic involvement. J. Am. Acad. Dermatol. 1984; 11: 371–4.

    Article  PubMed  CAS  Google Scholar 

  31. Narisawa Y, Kojima T, Iriki A, et al. Tissue changes in cryptococcosis: histologic alteration from gelatinous to suppurative tissue response with asteroid body. Mocopathologia 1989; 106: 113–9.

    Article  CAS  Google Scholar 

  32. Hirsh BC, Johnson WC. Pathology of granulomatous disease. Mixed inflammatory granulomas. Int. J. Dermatol. 1984; 23: 585–97.

    Article  PubMed  CAS  Google Scholar 

  33. Ro JY, Lee SS, Ayala AG. Advantage of Fontana Masson in capsule-deficient cryptococcal infection. Arch. Pathol. Lab. Med. 1987; 111: 53–7.

    PubMed  CAS  Google Scholar 

  34. Farmer SG, Komorowski RA. Histologic response to capsule-deficient Cryptococcus neoformans. Arch. Pathol. 1973; 96: 383–7.

    PubMed  CAS  Google Scholar 

  35. Naka W, Masuda M, Konohana A, et al. Primary cutaneous cryptococcosis and Cryptococcus neoformans serotype D. Clin. Exp. Dermatol. 1995; 20: 221–5.

    Article  CAS  Google Scholar 

  36. Pappagianis D. Coccidioidomycosis. Semin. Dermatol. 1993; 12: 301–9.

    PubMed  CAS  Google Scholar 

  37. Stevens DA. Coccidioidomycosis. N. Engl. J. Med. 1995; 332: 1077–82.

    Article  PubMed  CAS  Google Scholar 

  38. Quimby SR, Connolly SM, Winkelmann RK, et al. Clincopathologic spectrum of specific cutaneous lesions of disseminated coccidioidomycosis. J. Am. Acad. Dermatol. 1992; 26: 79–85.

    PubMed  CAS  Google Scholar 

  39. Hobbs E. Coccidioidomycosis. Dermatol. Clin. 1989; 7: 227–39.

    PubMed  CAS  Google Scholar 

  40. Bronnimann DA, Galgiani JN. Coccidioidomycosis. Eur. J. Clin. Microbiol. Infect. Dis. 1989; 8: 466–73.

    Article  PubMed  CAS  Google Scholar 

  41. Fish DG, Ampel NM, Galgiani JN, et al. Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients. Medicine (Baltimore) 1990; 69: 384–91.

    CAS  Google Scholar 

  42. Prichard JC, Sorotzkin RA, James RE III. Cutaneous manifestations of disseminated coccidioidomycosis in the acquired immunodeficiency syndrome. Cutis 1987; 39: 203–5.

    PubMed  CAS  Google Scholar 

  43. Schwartz RA, Lamberts RJ. Isolated nodular cutaneous coccidioidomycosis. The initial manifestion of disseminated disease. J. Am. Acad. Dermatol. 1981; 4: 38–46.

    PubMed  CAS  Google Scholar 

  44. Bayer AS, Yoshikawa TT, Galpin JE, Guze LB. Unusual syndromes of coccidioidomycosis: diagnostic and therapeutic considerations: a report of 10 cases and review of the English literature. Medicine (Baltimore) 1976; 55: 131–52.

    Article  CAS  Google Scholar 

  45. Levan NE, Huntington RW Jr. Primary cutaneous coccidioidomycosis in agricultural workers. Arch. Dermatol. 1965; 92: 215–20.

    Article  Google Scholar 

  46. Ampel NM, Wieden MA, Galgiani JN. Coccidioidomycosis: clinical update. Rev. Infect. Dis. 1989; 11: 897–911.

    PubMed  CAS  Google Scholar 

  47. DiTomasso JP, Ampel NM, Sobonya RE, et al. Bronchoscopic diagnosis of pulmonary coccidioidomycosis. Comparison of cytology, culture and transbronchial biopsy. Diagn. Microbiol. Infect. Dis. 1994; 18: 83–7.

    Article  PubMed  CAS  Google Scholar 

  48. Pappagianis D, Zimmer BL. Serology of coccidioidomycosis. Clin. Microbiol. Rev. 1990; 3: 247–68.

    PubMed  CAS  Google Scholar 

  49. Carman WF, Frean JA, Cerwe-Brown HH, et al. Blastomycosis in Africa. A review of cases diagnosed between 1951 and 1987. Mycopathologia 1989; 107: 25–32.

    Article  PubMed  CAS  Google Scholar 

  50. Tenenbaum MJ, Greenspan J, Kerkering TM. Blastomycosis. Crit. Rev. Microbiol. 1982; 9: 139–63.

    Article  PubMed  CAS  Google Scholar 

  51. Malak JA, Farah FS. Blastomycosis in Middle East. Report of suspected case of North American blastomycosis. Br. J. Dermatol. 1971; 84: 161–6.

    Article  PubMed  CAS  Google Scholar 

  52. Bradsher RW. Blastomycosis. Clin. Inf. Dis. 1992; 14: S82–90.

    Google Scholar 

  53. Pladson TR, Stiles MA, Kuritsky JN. Pulmonary histoplasmosis. A possible risk in people who cut decayed wood. Chest 1984; 86: 435–8.

    Article  PubMed  CAS  Google Scholar 

  54. Dijkstra JWE. Histoplasmosis. Dermatol. Clin. 1989; 7: 251–7.

    PubMed  CAS  Google Scholar 

  55. Goodwin RA, Owens FT, Snell JD, et al. Chronic pulmonary histoplasmosis. Medicine (Baltimore) 1976; 55: 413–52.

    Google Scholar 

  56. Witty LA, Steiner F, Curfman M, et al. Disseminated histoplasmosis in patients receiving low-dose methotrexate therapy for psoriasis. Arch. Dermatol. 1992; 128: 91–3.

    Article  PubMed  CAS  Google Scholar 

  57. Studdard J, Sneed WF, Taylor MR Jr, et al. Cutaneous histoplasmosis. Am. Rev. Respir. Dis. 1976; 113: 689–93.

    PubMed  CAS  Google Scholar 

  58. Cohen PR, Bank DE, Silvers DN, et al. Cutaneous lesions of disseminated histoplasmosis in human immunodeficiency virus-infected patients. J. Am. Acad. Derm. 1990; 23: 422–8.

    PubMed  CAS  Google Scholar 

  59. Williams AO, Lawson EA, Lucas AO. African histoplasmosis due to Histoplasma duboisii. Arch. Pathol. 1971; 92: 306–18.

    PubMed  CAS  Google Scholar 

  60. Davies SF. Histoplasmosis: update 1989; Semin. Respir. Infect. 1990; 5: 93–104.

    PubMed  CAS  Google Scholar 

  61. Belknap BS. Sporotrichosis. Dermatol. Clin. 1989; 7: 193–202.

    PubMed  CAS  Google Scholar 

  62. Shiraishi H, Gomi H, Kawada A, et al. Solitary sporotrichosis lasting for 10 years. Dermatology 1999; 198: 100–1.

    Article  PubMed  CAS  Google Scholar 

  63. Purvis RS, Diven DG, Drechsel RD, et al. Sporotrichosis presenting as arthritis and subcutaneous nodules. J. Am. Acad. Dermatol. 1993; 28: 879–84.

    PubMed  CAS  Google Scholar 

  64. Urabe H, Honbo S. Sporotrichosis. Int. J. Dermatol. 1986; 25: 255–7.

    Article  PubMed  CAS  Google Scholar 

  65. Mayberry JD, Mullins JF, Stone OJ. Sporotrichosis with demonstration of hyphae in human tissue. Arch. Dermatol. 1966; 39: 65–7.

    Article  Google Scholar 

  66. Binford DH, Dooley JR. Sporotrichosis. Pathology of Tropical and Extraordinary diseases, Vol. 2; Bunford CH, Connor DH, eds. Washington: Armed Forces Institute of Pathology, 1976, pp 574–7.

    Google Scholar 

  67. Rajendran C, Ramesh V, Misra RS, et al. Chromoblastomycosis in India. Int. J. Dermatol. 1997; 36: 29–33.

    Article  PubMed  CAS  Google Scholar 

  68. Sharma NL, Sharma RC, Grover PS, et al. Chromoblastomycosis in India. Int. J. Dermatol. 1999; 38: 846–51.

    Article  PubMed  CAS  Google Scholar 

  69. Fukushiro R. Chromomycosis in Japan. Int. J. Dermatol. 1983; 22: 221–9.

    Article  PubMed  CAS  Google Scholar 

  70. Redondo-Bellon P, Idoate M, Rubio M, et al. Chromoblastomycosis produced by Aureobasidium pullulans in an immunosuppressed patient. Arch. Dermatol. 1997; 133: 663–4.

    Article  PubMed  CAS  Google Scholar 

  71. Tomecki KJ, Steck WD, Hall GS, et al. Subcutaneous mycoses. J. Am. Acad. Dermatol. 1989; 21: 785–90. Review.

    PubMed  CAS  Google Scholar 

  72. Bansal AS, Prabhakar P. Chromomycosis: a twenty-year analysis of histologically confirmed cases in Jamaica. Trop. Geogr. Med. 1989; 41: 222–6.

    PubMed  CAS  Google Scholar 

  73. Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin. Infect. Dis. 2000; 4: 710–8.

    Article  Google Scholar 

  74. Galgiani JN, Ampel NM, Catanzaro A, et al. Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America. Clin. Infect. Dis. 2000; 4: 658–61.

    Article  Google Scholar 

  75. Pappas PG, Threlkeld MG, Bedsole GD, et al. Blastomycosis in immunocompromised patients. Medicine (Baltimore) 1993; 72: 311–25.

    CAS  Google Scholar 

  76. Conti Diaz IA, Civila E, Gezuele E, et al. Treatment of human cutaneous sporotrichosis with itraconazole. Mycoses 1992; 35: 153–6.

    PubMed  CAS  Google Scholar 

  77. Dismukes WE, Stamm AM, Graybill JR, et al. Treatment of systemic mycoses with ketoconazole: an emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious diseases collaborative antifungal study. Ann. Intern. Med. 1983; 98: 13.

    PubMed  CAS  Google Scholar 

  78. Dismukes WE, Bradsher RW Jr, Cloud GC, et al. Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am. J. Med. 1992; 93: 489–97.

    Article  PubMed  CAS  Google Scholar 

  79. Wheat J, MaWhinney S, Hafner R, et al. Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group. Am. J. Med. 1997; 130: 223–32.

    Article  Google Scholar 

  80. Gotzsche, PC, Johansen HK. Meta-analysis of prophylactic or empirical antifungal treatment vs. placebo or no treatment in patients with cancer complicated by neutropenia. Brit. Med. J. 1997. 314: 1238–44.

    PubMed  CAS  Google Scholar 

  81. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoetic stem cell transplants: an international consensus. Clin. Infect. Dis. 2002; 34: 7–14.

    Article  PubMed  CAS  Google Scholar 

  82. Koneman EW, Allen SD, Janda WM, Schrenkengerger PC, Winn WC Jr. Color Atlas and Textbook of Diagnostic Microbiology, 5th ed. New York: Lippincott, Williams and Wilkins, 1997.

    Google Scholar 

  83. Allo MD, Miller J, Townsend T, et al. Primary cutaneous aspergillosis associated with Hickman intravenous catheters. New Eng. J. Med. 1987; 317: 1105–8.

    PubMed  CAS  Google Scholar 

  84. Romero LS, Hunt SJ, Hickman catheter associated primary cutaneous aspergillosis in a patient with the acquired immunodeficiency syndrome. Int. J. Dermatol. 1995; 34: 551–3.

    Article  PubMed  CAS  Google Scholar 

  85. Stiller MJ, Teperman L, Rosenthal SA, et al. Primary cutaneous infection by Aspergillus ustus in a 62-year-old liver transplant recipient. J. Am. Acad. Dermatol. 1994; 31: 344–7.

    PubMed  CAS  Google Scholar 

  86. Pla MP, Berenguer J, Arzuaga JA, et al. Surgical wound infection by Aspergillus fumigatus in liver transplant recipients. Diagn. Microbiol. Infect. Dis. 1992; 15: 703–6.

    Article  PubMed  CAS  Google Scholar 

  87. Findlay GH, Roux H, Simson I. Skin manifestations in disseminated aspergillosis. Brit. J. Dermatol. 1971; 85 (Suppl.): 94–7.

    Article  Google Scholar 

  88. Koneman EW and Roberts GD “Mycotic Disease” in Henry JB, ed. Clinical Diagnosis and Management by Laboratory Methods, 18th ed. Philadelphia: Saunders, 2001; pp. 1099–157.

    Google Scholar 

  89. Sugar, AM. Agents of Mucormycosis and Related Species. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 5th ed. New York: Churchill Livingstone, Inc., 2000, p. 2692.

    Google Scholar 

  90. Chandler FW and Watts JC. Pathologic Diagnosis of Fungal Infections. Chicago: ASCP Press, 1987.

    Google Scholar 

  91. Vusirikala M. Supportive care in hematologic malignancies. In Greer JP, Foerster J, Lukens JN, et al., eds. Wintrobe’s Clinical Hematology, 11th ed. Philadelphia: Lippincott, Williams and Wilkins, 2004, pp. 2102–13.

    Google Scholar 

  92. Fouassier M, Joly D, Cambon M, et al. Geotrichum capitatum infection in a neutropenic patient. Apropos of a case and review of the literature. Revue Med. Intern. 1998; 19: 431–3.

    CAS  Google Scholar 

  93. Listemann H, Schonrock-Nabulsi P, Kuse R, et al. Geotrichosis of oral mucosa. Mycoses 1996; 39: 289–91.

    PubMed  CAS  Google Scholar 

  94. Machet L, Jan V, Machet MC, et al. Cutaneous alternariosis: role of corticosteroid-induced cutaneous fragility. Dermatology 1996; 193: 342–4.

    Article  PubMed  CAS  Google Scholar 

  95. Ioannidou DJ, Stefanidou MP, Maraki SG, et al. Cutaneous alternariosis in a patient with idiopathic pulmonary fibrosis. Int. J. Dermatol. 2000; 39: 293–5.

    Article  PubMed  CAS  Google Scholar 

  96. Acland KM, Hay RJ, Groves R. Cutaneous infection with Alternaria alternata complicating immunosuppression: successful treatment with itraconazole. Br. J. Dermatol. 1998; 138:354–6.

    Article  PubMed  CAS  Google Scholar 

  97. Iwatsu T. Cutaneous alternariosis. Arch. Dermatol. 1988; 124(12): 1822–5.

    Article  PubMed  CAS  Google Scholar 

  98. Lespessailles E, Kerdraon R, Michenet P, et al. Alternaria infection of the skin and joints. A report of two cases involving the hand. Rev. Rhum, Engl, Ed. 1999; 66(10): 509–11.

    CAS  Google Scholar 

  99. Rippon JW. Medical Mycology: The pathogenic fungi and the pathogenic Actinomycetes, 3rd ed. Philadelphia: WB Saunders, 1988, p. 482.

    Google Scholar 

  100. Bodey GP, Boktour M, Mays S, et al. Skin lesions associated with Fusarium infection. J. Am. Acad. Dermatol. 2002; 47: 659–66.

    Article  PubMed  Google Scholar 

  101. Frediank H. Hyalohyphomycoses due to Fusarium spp.—two case reports and review of the literature. Mycoses 1995; 38(1): 69–74.

    Google Scholar 

  102. Collins MS, Rinaldi MG. Cutaneous infection in man caused by Fusarium moniliforme. Sabouraudia 1977; 15: 151–60.

    PubMed  CAS  Google Scholar 

  103. Anaissie E, Legrand C, Hachem R, et al. Recovery of Fusarium sp from the bloodstream using a rabbit model of systemic fusariosis. Abstracts from the Annual Meeting of the American Society of Microbiology 1990; 90: 413 (abstr F-28).

    Google Scholar 

  104. Peltroche-Llacsahuanga H, Manegold E, Kroll G, et al. Case report. Pathohistological findings in a clinical case of disseminated infection with Fusarium oxysporum. Mycoses 2000; 43(9–10): 367–72.

    Article  PubMed  CAS  Google Scholar 

  105. Musa MO, Al Eisa A, Halim M, et al. The spectrum of Fusarium infection in immunocompromised patients with hematological malignancies and in non-immunocompromised patients: a single institution experience over 10 years. Br. J. Haematol. 2000; 108(3): 544–8.

    Article  PubMed  CAS  Google Scholar 

  106. Romano C, Massai L, De Alo GB, et al. A Case of Primary Cutaneous Actinomycosis. Acta Derm. Venereol. 2002; 82: 144–5.

    Article  PubMed  Google Scholar 

  107. Song WK, Park HJ, Cinn YW, et al. Primary cutaneous mucormycosis in a trauma patient. J. Dermatol. 1999; 26(12):825–8.

    PubMed  CAS  Google Scholar 

  108. Adriaenssens K, Jorens PG, Meuleman L, et al. A black necrotic skin lesion in an immunocompromised patient. Diagnosis: cutaneous mucormycosis. Arch. Dermatol. 2000; 136: 1165–70.

    Article  PubMed  CAS  Google Scholar 

  109. Kobayashi M, Hiruma M, Matsushita A, et al. Cutaneous zygomycosis: a case report and review of Japanese reports. Mycoses 2001; 44: 311–15.

    Article  PubMed  CAS  Google Scholar 

  110. Wu CL, Hsu WH, Huang CM, et al. Indolent cutaneous mucormycosis with pulmonary dissemination in an asthmatic patient: survival after local debridement and amphotericin B therapy. J. Formos Med. Assoc. 2000; 99: 354–7.

    PubMed  CAS  Google Scholar 

  111. Tortora GJ, Funke B, Case CL. Microbiology: An Introduction, 5th ed. Addison-Wesley, 1995.

    Google Scholar 

  112. Esteban J. Zaparadiel J, Soriano F. Two cases of soft-tissue infection caused by Arcanobacterium haemolyticum. Clin. Infect. Dis. 1994; 18: 35–6.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Associate Dermotology UCSF, San Francisco

    Sadia Saeed MD

  2. Clinical Associate Pathology USFCOM, Tampa

    Elizabeth Sagatys MD

  3. Clinical Associate Dermatology, University of Chicago, Chicago

    Justin R. Wasserman

  4. Haley VA Hospital, USF College of Medicine, Department of Pathology, Tampa, FL, USA

    Michael B. Morgan MD

Authors
  1. Sadia Saeed MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth Sagatys MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Justin R. Wasserman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael B. Morgan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dermatology Healthcare, Tampa, FL, USA

    Robert A. Norman DO, MPH, FAAIM

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Saeed, S., Sagatys, E., Wasserman, J.R., Morgan, M.B. (2008). Geriatric Fungal Infections. In: Norman, R.A. (eds) Diagnosis of Aging Skin Diseases. Springer, London. https://doi.org/10.1007/978-1-84628-678-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-678-0_11

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-677-3

  • Online ISBN: 978-1-84628-678-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation